# Clinical Study of DMT in Healthy Adults

> **NCT05573568** · PHASE1 · COMPLETED · sponsor: **Biomind Labs Inc.** · enrollment: 27 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** N,N-Dimethyltryptamine

## Key facts

- **NCT ID:** NCT05573568
- **Lead sponsor:** Biomind Labs Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-14
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573568, "Clinical Study of DMT in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05573568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*